Skip to Content

Kane Biotech Inc KNBIF Stock Quote

| Rating as of


Market Closed

| Currency in USD

  • Last Close 0.06
  • Sector Healthcare
  • Industry Biotechnology
  • Investment Style Small Growth
  • Day Range 0.06  –  0.06
  • Year Range 0.05  –  0.11
  • Market Cap 7.3872 Mil
  • Volume / Avg 3,000.0 /  6,769.6
  • Price / Sales 3.30
  • Price / Book
  • Forward Div Yield 17.81%
  • Trailing Div Yield

Morningstar‘s Stock Analysis KNBIF

Currency in
Is it the right time to buy or sell?
Is it the right time to buy or sell?

1-Star Price


5-Star Price


Economic Moat


About Quantitative Ratings

Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.

Unlock Our Full Analysis With Morningstar Investor

Key Statistics KNBIF

Company Profile KNBIF

Business Description

Kane Biotech Inc is a biotechnology company engaged in the research, development and commercialization of technologies and products that prevent and remove microbial biofilms. The company has a portfolio of biotechnologies, intellectual property and products developed by its own biofilm research expertise and acquired from research institutions. The Company has a separate operating segment for its Stem Animal Health subsidiary, which operates the animal health business. StrixNB, DispersinB, Aledex, bluestem, bluestem, silkstem, goldstem, coactiv+, DermaKB and DermaKB Biofilm are trademarks of the company. The firm is also engaged in the animal health business through its Stem Animal Health subsidiary.

290-100 Innovation Drive
Winnipeg, MB, R3T 6G2, CAN
Industry Biotechnology

Competitors & Peers KNBIF

Morningstar does not cover competitors or peers for this firm.

FAQs for Kane Biotech Inc Stock

No. KNBIF does not currently have a forward dividend yield.
Dividend yield allows investors, particularly those interested in dividend-paying stocks, to compare the relationship between a stock’s price and how it rewards stockholders through dividends. The formula for calculating dividend yield is to divide the annual dividend paid per share by the stock price.

Learn more about dividend yield.

KNBIF’s market cap is 7.39 Mil.
Market capitalization is calculated by taking a company’s share price and multiplying it by the total number of shares. It’s often used to measure a company’s size. In the Morningstar Style Box, large-cap names account for the largest 70% of U.S. stocks, mid-cap names account for the largest 70–90%, and small-cap names are the remaining 10% of companies.

Learn more about market capitalization.

KNBIF’s stock style is Small Growth.
Style is an investment factor that has a meaningful impact on investment risk and returns. Style is calculated by combining value and growth scores, which are first individually calculated.

High-growth stocks tend to represent the technology, healthcare, and communications sectors. They rarely distribute dividends to shareholders, opting for reinvestment in their businesses. More value-oriented stocks tend to represent financial services, utilities, and energy stocks. These are established companies that reliably pay dividends.

Learn more about style.

KNBIF’s beta can be found in Trading Information at the top of this page.
A stock’s beta measures how closely tied its price movements have been to the performance of the overall market.

Compare KNBIF’s historical performance against its industry peers and the overall market.